Your browser doesn't support javascript.
loading
TET2 Mutations Affect Non-CpG Island DNA Methylation at Enhancers and Transcription Factor-Binding Sites in Chronic Myelomonocytic Leukemia.
Yamazaki, Jumpei; Jelinek, Jaroslav; Lu, Yue; Cesaroni, Matteo; Madzo, Jozef; Neumann, Frank; He, Rong; Taby, Rodolphe; Vasanthakumar, Aparna; Macrae, Trisha; Ostler, Kelly R; Kantarjian, Hagop M; Liang, Shoudan; Estecio, Marcos R; Godley, Lucy A; Issa, Jean-Pierre J.
Afiliação
  • Yamazaki J; Fels Institute for Cancer Research and Molecular Biology, Temple University, Philadelphia, Pennsylvania. Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Jelinek J; Fels Institute for Cancer Research and Molecular Biology, Temple University, Philadelphia, Pennsylvania. Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lu Y; Department of Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Cesaroni M; Fels Institute for Cancer Research and Molecular Biology, Temple University, Philadelphia, Pennsylvania.
  • Madzo J; Fels Institute for Cancer Research and Molecular Biology, Temple University, Philadelphia, Pennsylvania. Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois.
  • Neumann F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • He R; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Taby R; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Vasanthakumar A; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois.
  • Macrae T; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois.
  • Ostler KR; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois.
  • Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Liang S; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Estecio MR; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Godley LA; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois.
  • Issa JP; Fels Institute for Cancer Research and Molecular Biology, Temple University, Philadelphia, Pennsylvania. Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas. jpissa@temple.edu.
Cancer Res ; 75(14): 2833-43, 2015 Jul 15.
Article em En | MEDLINE | ID: mdl-25972343
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Leucemia Mielomonocítica Crônica / Proteínas Proto-Oncogênicas / Elementos Facilitadores Genéticos / Metilação de DNA / Mutação de Sentido Incorreto / Proteínas de Ligação a DNA Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Leucemia Mielomonocítica Crônica / Proteínas Proto-Oncogênicas / Elementos Facilitadores Genéticos / Metilação de DNA / Mutação de Sentido Incorreto / Proteínas de Ligação a DNA Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article